Jeffrey Stein - 10 Dec 2025 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
President & CEO, Director
Signature
/s/ Shane Ward, Attorney-in-Fact
Issuer symbol
CDTX
Transactions as of
10 Dec 2025
Net transactions value
$0
Form type
4
Filing time
29 Dec 2025, 18:04:14 UTC
Previous filing
26 Jun 2025
Next filing
07 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stein Jeffrey President & CEO, Director 6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO /s/ Shane Ward, Attorney-in-Fact 29 Dec 2025 0001478831

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Gift $0 -33,072 -59% $0.000000 23,127 10 Dec 2025 Direct F1
transaction CDTX Common Stock Gift $0 +33,072 +135% $0.000000 57,652 10 Dec 2025 By trust F1
transaction CDTX Common Stock Gift $0 -2,244 -9.7% $0.000000 20,883 17 Dec 2025 Direct F1
transaction CDTX Common Stock Gift $0 +2,244 +3.9% $0.000000 59,896 17 Dec 2025 By trust F1
transaction CDTX Common Stock Gift $0 -10,638 -51% $0.000000 10,295 19 Dec 2025 Direct F1, F2
transaction CDTX Common Stock Gift $0 +10,638 +18% $0.000000 70,534 19 Dec 2025 By trust F1
transaction CDTX Common Stock Gift $0 -5,425 -7.7% $0.000000 65,109 22 Dec 2025 By trust F3
holding CDTX Common Stock 2,100 10 Dec 2025 By son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Gift transfer of shares from Reporting Person to trust for no consideration.
F2 Includes 50 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on December 18, 2025.
F3 This transaction reflects a bona fide gift of the Issuer's stock to a donor-advised fund (DAF) for charitable purposes. The Reporting Person retains no beneficial ownership or control over the donated securities following the contribution.